Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -1.36 (-4.08%)
Bid:
32.12
Ask:
32.22
Spread: 0.10 (0.311%)
Market Cap: £507.79m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Trading Statement

21 Apr 2026 07:00

RNS Number : 2087B
THG PLC
21 April 2026
 

21 April 2026

 

THG PLC

 

First quarter trading statement for the period ended 31 March 2026

 

 

Strongest Group Q1 revenue growth since Covid 2021 (+7.0%)

 

THG Beauty revenue growth accelerated to +5.8%, driven by a strong US performance and 7% order growth in the core UK market

 

THG Nutrition revenue growth of +8.8% (+12.1% ex-Asia)

 

Full year guidance reiterated

 

 

Q1 2026 Group trading performance

 

£m

Q1

2026

YoY

Growth

Continuing[1] CCY[2]

THG Beauty

233.3

+2.4%

+5.8%

THG Nutrition

159.8

+8.1%

+8.8%

Total revenue

393.1

+4.6%

+7.0%

 

All comparative figures are continuing CCY unless otherwise stated, all numbers and tables subject to rounding.

 

Q1 2026 revenue growth of +7.0% representing the Group's best Q1 growth performance since 2021, with Beauty accelerating on H2 2025 (+5.8% vs +5.4% H2 2025). Growth was modestly impacted by disruption in the Middle East (c.30bps), with underlying growth accelerating on Q4 exit trends.

 

As previously guided, the combined impact of disposals and discontinued activities reduced Group Q1 2026 revenue growth by 150bps, with the currency headwinds most pronounced in the US.

 

THG Beauty delivered continued retail momentum, with Lookfantastic outperforming the UK prestige beauty market[3], driven by growth in orders and active customers.

 

THG Nutrition grew across all channels, with expansion into higher-margin categories such as activewear, creatine, hydration and collagen, alongside pricing and product optimisation, helping to offset elevated whey costs.

 

Outlook and guidance

 

Following a strong start to the year, the Group maintains its guidance for FY 2026[4], underpinned by continued market share gains in key territories and the successful implementation of pricing and product optimisation strategies.

The Group continues to monitor developments in the Middle East with affected regions representing less than 1.5% of Group revenue in FY 2025, weighted towards THG Beauty.

Strongest Q1 cash flow performance in three years, underpinning full year free cash flow guidance of £25m to 50m.

 

Matthew Moulding, CEO of THG commented:

 

"It is energising for everyone at THG to see such a strong start to 2026, building on the better-than-expected momentum we delivered in H2 2025.

 

In Beauty, Lookfantastic is once again outperforming the market following two years of business model change, while the US continues to perform strongly.

 

In Nutrition, our diversification into margin-accretive categories is now clearly paying dividends. Activewear continues to deliver exceptional growth, with annualised run-rate sales fast approaching £100m. Growth across activewear and other high-margin categories, including creatine, hydration and collagen, is helping to offset record whey commodity pricing.

 

While the geopolitical backdrop remains uncertain, we enter Q2 with confidence after a better-than-expected Q1, giving us a stronger base against any unforeseen risks later in the year."

 

 

THG Beauty Q1 2026 highlights

 

THG Beauty entered 2026 with significant momentum in UK and US retail. In the UK, orders grew by 7% alongside growth in the LTM active customer base.

US retail saw revenue growth and market share expansion[5], driven by a 10% increase in new customers. Dermstore became one of the first major online beauty retailers to partner with Flex, enabling customers to pay for a significantly greater amount of their skincare regime with their pre-tax earnings through Health Savings (HSA) and Flexible Spending (FSA) accounts directly at checkout, improving affordability and convenience whilst supporting AOV increases.

The K-Beauty category was a standout performer, with revenue more than doubling YoY, supported by the launch of six new brands YTD. Across the platform, new brand launches continued to support growth with SkinCeuticals and MAC exceeding expectations since their launch on Cult Beauty.

The new Lookfantastic store in Bristol is outperforming the initial flagship store launch, creating a localised halo effect supporting brand awareness and new customer acquisition.

The own-brand portfolio is building on the lifecycle investments made in 2025, securing new retail and spa listings for Ameliorate and ESPA. Within manufacturing, revenue growth is driven by strategic new business wins alongside continued growth from its existing customer base.

 

THG Nutrition Q1 2026 highlights

 

Revenue growth (+8.8%) was broad-based across online and offline channels, with expansion into gross margin accretive categories including activewear and creatine helping to mitigate elevated whey prices. The core powder range was also optimised through reformulation and strategic pricing, alongside the launch of MARS® Impact Whey Protein.

The intentional pivot in Asia to license with pre-eminent local manufacturing and distribution partners has resulted in a revenue decline in these regions as the business rebuilds on structurally higher-margin foundations. Growth in Asia will resume once the structural transition has been annualised in the comparatives. Excluding this territory, THG Nutrition delivered revenue growth of +12.1%.

 

C.15% of active customers purchased activewear in Q1 (+230bps YoY), with AOVs on orders including activewear c.31% higher. The range aims to introduce the brand to new customers through expanding beyond performance wear to lifestyle audiences, supported by the recent launch of Myprotein's collaboration with Champion and upcoming launch in high-footfall Footasylum stores.

Myprotein's licensed out range delivered >200% growth in units sold into retail YoY, supported by the launch of Greencore food on-the-go items and expansion of the Müller range. In addition, the partnership with Jimmy's Iced Coffee, now holds a c.20% share of the protein coffee sub-category[6], underlining the strength of the brand in adjacent categories.

UK and international retail expansion continued at pace with Myprotein achieving record market share value in the UK total sports nutrition category[7]. Initiatives launching towards the end of the quarter building into Q2/Q3 include;

 

launching branded bays in Tesco stores nationwide, bringing several categories together in one location driving trial and discovery;

entering Canada and Latin America with new distribution partners alongside a marketplace presence;

launching in 1,200 Kroger stores in the US in June, complementing existing major grocer listings including Walmart and Meijer;

expanding presence with GNC (4 x Clear Whey RTD SKUs in 1,500 stores) and Vitamin Shoppe (first-to-market launch of Myprotein Gummies range).

 

 

For further information please contact:

 

Investor enquiries - THG PLC

Kate Grimoldby, Director of Investor Relations and Strategic Projects

Investor.relations@thg.com

 

Media enquiries:

Sodali & Co - Financial PR adviser

Tel: +44 (0) 20 7100 6451

Russ Lynch/Sam Austrums/Louisa Henry

thg@sodali.com

 

THG PLC

 

 

media-enquiries@thg.com

Notes to Editors 

THG PLC is a global e-commerce group and brand owner headquartered in Manchester, UK, which operates through two leading consumer businesses: THG Beauty and THG Nutrition.

 

THG Beauty operates prominent online platforms including Lookfantastic, Dermstore and Cult Beauty, offering a valued route to market for over 1,000 third-party brands, alongside a specialist portfolio of owned brands.

 

THG Nutrition, led by Myprotein, the world's largest online sports nutrition brand, spans multiple health and wellness categories, delivering its products both directly to consumers and through strategic offline partnerships worldwide. 

 

 

Cautionary Statement

Certain statements included within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation.

 

 

 

Appendix

 

Quarterly continuing constant currency revenue growth rate

 

Q1

2024

Q2

2024

Q3

2024

Q4

2024

FY

2024

Q1

2025

Q2

2025

Q3

2025

Q4

2025

H1

2025

H2

2025

FY

2025

Q1

2026

THG Beauty

+13.6%

+3.5%

+3.2%

+0.8%

+4.6%

-9.8%

-2.1%

+4.2%

+6.3%

-5.9%

+5.4%

+0.2%

+5.8%

THG Nutrition

-5.7%

-9.4%

-10.5%

-9.4%

-8.7%

+0.3%

+6.2%

+10.0%

+9.5%

+3.2%

+9.7%

+6.4%

+8.8%

Total revenue

+5.5%

-1.5%

-2.0%

-2.5%

-0.4%

-6.1%

+0.9%

+6.3%

+7.2%

-2.5%

+6.8%

+2.3%

+7.0%

 

Quarterly reported growth rate

 

Q1

2024

Q2

2024

Q3

2024

Q4

2024

FY

2024

Q1

2025

Q2

2025

Q3

2025

Q4

2025

H1

2025

H2

2025

FY

2025

Q1

2026

THG Beauty

+3.9%

-2.5%

-3.1%

-8.0%

-3.1%

-15.3%

-9.6%

-1.2%

+2.1%

-12.4%

+0.7%

-5.4%

+2.4%

THG Nutrition

-12.2%

-15.0%

-14.0%

-13.1%

-13.6%

-2.3%

+4.5%

+9.3%

+9.0%

+1.1%

+9.2%

+5.0%

+8.1%

Total revenue

-2.6%

-7.3%

-7.1%

-9.5%

-6.8%

-10.6%

-4.7%

+2.4%

+4.1%

-7.6%

+3.3%

-2.0%

+4.6%

 

Quarterly reported revenue

 

 £m

Q1

2024

Q2

2024

Q3

2024

Q4

2024

FY

2024

Q1

2025

Q2

2025

Q3

2025

Q4

2025

H1

2025

H2

2025

FY

2025

Q1

2026

THG Beauty

268.9

278.8

261.3

362.2

1,171.1

227.8

252.0

258.2

369.8

479.9

628.0

1,107.9

233.3

THG Nutrition

151.3

149.1

134.5

145.4

580.3

147.8

155.8

147.0

158.6

303.6

305.6

609.1

159.8

Total revenue

420.2

427.8

395.7

507.6

1,751.4

375.6

407.8

405.2

528.3

783.4

933.6

1,717.0

393.1

 

 

 

Ends

 


[1] Continuing excludes discontinued categories and Claremont Ingredients, the sale of which completed on 2 September 2025.

[2] CCY defined as constant currency basis.

[3] Market Growth; Circana Total Market 04/01/2026 - 28/03/2026.

[4] Consensus dated 20/04/2026 and available at https://www.thg.com/investor-relations/analyst-consensus.

[5] NielsenIQ Digital Purchases, Total US, Beauty Categories (Cosmetics & Nails, Skin Care, Fragrance, Hair Care) 01/01/2026 - 28/02/2026.

[6] Source: NielsenIQ (NIQ), Total Coverage GB, Protein RTD Coffee, Value Sales, 4 w/e 28/03/2026.

[7] Nielson UK Retail Market - Total Sports Nutrition Category: 01/01/2026 - 21/02/2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIISEIIFIR
Date   Source Headline
1st Apr 202511:55 amRNSTR-1: Notification of Major Holdings
1st Apr 202511:47 amRNSEquity Raise Post-Transaction Report
1st Apr 202510:20 amRNSTR-1: Notification of Major Holdings
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 202511:44 amRNSTR-1: Notification of Major Holdings
31st Mar 202510:45 amRNSPDMR / PCA Shareholding & TR-1 Notification
27th Mar 20257:00 amRNSEquity Contribution confirmation
25th Mar 20257:00 amRNSResults of Placing
24th Mar 20255:45 pmRNSProposed debt refinancing and equity placing
7th Mar 20253:24 pmRNSTR-1: Notification of Major Holdings
6th Mar 20257:00 amRNSInclusion in FTSE 250 Index
3rd Mar 20257:00 amRNSTotal Voting Rights
5th Feb 20259:34 amRNSTR-1: Notification of Major Holdings
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20257:01 amRNSTR-1: Notification of Major Holdings
28th Jan 20257:00 amRNSAppointment of Independent Non-Executive Director
23rd Jan 20257:00 amRNSQ4 2024 Trading Statement
20th Jan 20255:12 pmRNSNotice of Results
13th Jan 20257:00 amRNSTR-1: Notification of Major Holdings
9th Jan 20252:29 pmRNSTR-1: Notification of Major Holdings
8th Jan 202512:51 pmRNSDirectorate Change
7th Jan 20258:26 amRNSPDMR/PCA Shareholdings
6th Jan 202512:30 pmRNSTR-1: Notification of Major Holdings
6th Jan 20259:09 amRNSTransfer to ESCC Category
3rd Jan 20251:29 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20254:04 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20254:02 pmRNSTR-1: Notification of Major Holdings
2nd Jan 20252:09 pmRNSCompletion of Demerger
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 20242:36 pmRNSResults of General Meeting
17th Dec 20245:20 pmRNSIngenuity Shareholders’ Agreement & Articles
28th Nov 20247:01 amRNSIngenuity Demerger Circular and Notice of GM
28th Nov 20247:00 amRNSESCC transfer effective date, Index eligibility
27th Nov 20243:26 pmRNSAppointment of Corporate Broker
1st Nov 20247:00 amRNSBlock Listing Six Monthly Return
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSTR-1: Notification of Major Holdings
16th Oct 20247:00 amRNSPDMR/PCA Shareholdings
15th Oct 20244:41 pmRNSTR-1: Notification of Major Holdings
15th Oct 20244:29 pmRNSEquity Raise Post-Transaction Report
15th Oct 20244:27 pmRNSTR-1: Notification of Major Holdings
15th Oct 20244:24 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSResults of Placing
10th Oct 20244:54 pmRNSLaunch of Retail Offer
10th Oct 20244:52 pmRNSUpdate on Ingenuity Demerger and Proposed Placing
10th Oct 20244:50 pmRNSQ3 2024 Trading Statement
4th Oct 202410:09 amRNSTR-1: Notification of Major Holdings
1st Oct 20247:00 amRNSTotal Voting Rights
17th Sep 20247:01 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.